Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription. 2021

Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.

Extrachromosomal, circular DNA (ecDNA) is emerging as a prevalent yet less characterized oncogenic alteration in cancer genomes. We leverage ChIA-PET and ChIA-Drop chromatin interaction assays to characterize genome-wide ecDNA-mediated chromatin contacts that impact transcriptional programs in cancers. ecDNAs in glioblastoma patient-derived neurosphere and prostate cancer cell cultures are marked by widespread intra-ecDNA and genome-wide chromosomal interactions. ecDNA-chromatin contact foci are characterized by broad and high-level H3K27ac signals converging predominantly on chromosomal genes of increased expression levels. Prostate cancer cells harboring synthetic ecDNA circles composed of characterized enhancers result in the genome-wide activation of chromosomal gene transcription. Deciphering the chromosomal targets of ecDNAs at single-molecule resolution reveals an association with actively expressed oncogenes spatially clustered within ecDNA-directed interaction networks. Our results suggest that ecDNA can function as mobile transcriptional enhancers to promote tumor progression and manifest a potential synthetic aneuploidy mechanism of transcription control in cancer.

UI MeSH Term Description Entries
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D002843 Chromatin The material of CHROMOSOMES. It is a complex of DNA; HISTONES; and nonhistone proteins (CHROMOSOMAL PROTEINS, NON-HISTONE) found within the nucleus of a cell. Chromatins
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D063646 Carcinogenesis The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. Tumorigenesis,Oncogenesis,Carcinogeneses,Oncogeneses,Tumorigeneses

Related Publications

Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
May 2022, Cancer cell international,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
December 2016, Cell cycle (Georgetown, Tex.),
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
December 1990, Molecular and cellular biology,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
January 2020, Nature genetics,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
January 2024, Nature communications,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
February 2020, Cancer cell,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
January 2021, Frontiers in veterinary science,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
October 2022, Signal transduction and targeted therapy,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
August 1991, Cell,
Yanfen Zhu, and Amit D Gujar, and Chee-Hong Wong, and Harianto Tjong, and Chew Yee Ngan, and Liang Gong, and Yi-An Chen, and Hoon Kim, and Jihe Liu, and Meihong Li, and Adam Mil-Homens, and Rahul Maurya, and Chris Kuhlberg, and Fanyue Sun, and Eunhee Yi, and Ana C deCarvalho, and Yijun Ruan, and Roel G W Verhaak, and Chia-Lin Wei
June 2021, Cancer discovery,
Copied contents to your clipboard!